Male Infertility

Male infertility is on the rise in society. Approximately 15% of married couples have trouble conceiving despite having regular unprotected sex for more than a year. Out of the couples who are in their thirties, only 30% are able to conceive within the first three months; the rest have trouble due to male infertility issues.

Causes of Male Infertility

Infertility is a reproductive system disorder which results in the inability of a couple to procreate. The reasons for not being able to conceive can be varied and could be related to either partner. When the reproductive system of the male has a problem which makes it difficult for the couple to have a child, it is termed male infertility.

Sperm Production Problems

Erection and Ejaculation Problems

Blockage of Sperm Transport

Preventing Male Infertility

Male Infertility Research

Male Infertility Epidemiology

How is Male Infertility Diagnosed?

Fertility and Age

Low Sperm Count

Causes of a Low Sperm Count

Testing for a Low Sperm Count

See more featured articles »

Intracytoplasmic Sperm Injection (ICSI)

Latest Male Infertility News and Research

Obesity strikes below the belt: Study reveals link between obesity and male infertility

The influence of obesity on male fertility is still under debate. In the present investigation, researchers scrutinized semen samples from both obese individuals and those of normal weight. The aim was to explore the relationship between obesity, the length of sperm telomeres, levels of mRNA associated with autophagy, and diverse semen characteristics.

29 May 2023

The potential variations in sperm quality of infertile patients during the COVID-19 pandemic

A recent study investigated how SARS-CoV-2 infection affected the semen quality of infertile men in Tunisia.

10 May 2023

To what extent does air pollutant-induced semen damage contribute to male infertility?

Researchers investigate the contribution of air pollutants-induced semen damage to the risk of infertility.

25 Apr 2023

Gene discovery could pave the way for a non-hormonal male contraceptive

Discovery of a gene in multiple mammalian species could pave the way for a highly effective, reversible and non-hormonal male contraceptive for humans and animals.

17 Apr 2023

New microfluidic technology enables reliable selection of high-quality sperm for IVF success

Scientists have developed new technology to help couples undergoing in-vitro fertilization (IVF) due to male fertility problems to increase their chances of success in having a baby.

6 Apr 2023

Antioxidant supplementation shows potential to improve male fertility

A new study discusses the benefits of antioxidant supplementation on male fertility.

4 Apr 2023

Research evaluates the effects of physical agents on male fertility

A recent study published in The Archives of Italian Urology and Andrology summarized work-related risk factors of male infertility.

21 Mar 2023

Shorter ejaculation abstinence times linked to better reproductive outcomes during fertility treatments

Researchers evaluate the association between ejaculatory abstinence time, rates of pregnancies and live births, and DNA fragmentation.

20 Mar 2023

ANDRONET COST Action aims to improve research, education, and public awareness in andrology

Raising awareness of male health: ANDRONET COST Action to improve research, education, and public awareness in the field of andrology.

13 Mar 2023

Study sheds new light on a key protein involved in the process of spermiation

In order to achieve good times in their races, many Olympic swimmers wear swimsuits that are low in water resistance.

13 Mar 2023

Men who regularly lift heavy objects at work have higher sperm counts, study suggests

A new study from researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, suggests that men who regularly lift heavy objects at work have higher sperm counts.

22 Feb 2023

Declining PSA levels predict improved survival rates in men with non-metastatic castration-resistant prostate cancer

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic castration-resistant prostate cancer (nmCRPC), reports The Journal of Urology, an Official Journal of the American Urological Association.

10 Feb 2023

Top urologists share their insights and practical tips at "Urology on the Beach"

Desai Sethi Urology Institute brings renowned thought leaders to Miami Beach. From urologic cancers to female urology to male infertility to kidney stones and sexual health, top urologists from throughout the nation shared their insights and practical tips at "Urology on the Beach," a conference hosted January 13-15 by the Desai Sethi Urology Institute at the University of Miami Miller School of Medicine.

27 Jan 2023

Study: FER1L5 protein essential for sperm to undergo acrosome reaction and male fertility

Fertilization is the union of two cells: an egg and a sperm. Before the egg and the sperm fuse, an event known as the "acrosome reaction" needs to occur in the sperm.

25 Jan 2023

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in The Journal of Urology, an Official Journal of the American Urological Association.

11 Jan 2023

Cryoablation is more effective than heat-based treatment for some small kidney cancers

For patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer by freezing – called cryoablation – yields a lower-risk of cancer-related death compared to heat-based thermal ablation, reports a preliminary study in The Journal of Urology®, an Official Journal of the American Urological Association.

29 Nov 2022

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

For patients with solitary metastases from prostate cancer, an approach called metastasis-directed therapy (MDT) – focused treatment using surgery or radiation therapy, without androgen deprivation therapy (ADT) – can slow the time to cancer progression, reports a study in The Journal of Urology, an Official Journal of the American Urological Association

10 Nov 2022

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

Oral anticoagulant drug may be safe, effective in preventing blood clots after urologic cancer surgery

The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related complications after surgery, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.

12 Sep 2022

Neoadjuvant NHAs followed by surgery can improve key outcomes in high-risk prostate cancer patients

For high-risk patients with prostate cancer, treatment with novel hormonal agents (NHAs) followed by surgery can reduce the risk of recurrent and progressive cancer, compared to initial treatment with surgery, suggests a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA).

12 Sep 2022

Male Infertility

Overview

Sperm Production Problems

Erection and Ejaculation Problems

Blockage of Sperm Transport